Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and tolerability of vitamin C
(ascorbic acid) given by injection into the vein.
The second and third purpose of conducting this study is to observe any evidence of tumor
response to the vitamin C and compare the level of fatigue (weakness), pain control, ability
to do things, and quality of life, before and after vitamin C is given.